NEW YORK (360Dx) – Health Network Laboratories announced today the acquisition of Connective Tissue Gene Tests, a molecular diagnostic laboratory specializing in inherited genetic disorders.
CTGT, founded in 2004, uses proprietary analytic methods and a mutation database to provide more than 3,000 unique tests covering 1,000 genes. The company's systems have enabled it to rapidly develop and deploy new tests, according to HNL.